Journal of Endotoxin Research

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puel, A.
Right arrow Articles by Casanova, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puel, A.
Right arrow Articles by Casanova, J.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Endotoxin Research, Vol. 11, No. 4, 220-224 (2005)
DOI: 10.1177/09680519050110040601

Heritable defects of the human TLR signalling pathways

Anne Puel

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France, puel{at}necker.fr

Kun Yang

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France, French-Chinese Laboratory of Genetics and Life Sciences, Rui-Jin Hospital, Shanghai University, Shanghai, China

Cheng-Lung Ku

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France

Horst von Bernuth

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France

Jacinta Bustamante

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France

Orchidée Filipe Santos

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France

Tatiana Lawrence

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France

Huey-Hsuan Chang

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France

Hamoud Al-Mousa

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France, Pediatric Hematology-Immunology Unit, Necker Hospital, Paris, France

Capucine Picard

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France, Pediatric Hematology-Immunology Unit, Necker Hospital, Paris, France

Jean-Laurent Casanova

Laboratory of Human Genetics of Infectious Diseases, University of Paris-INSERM U550, Necker Medical School, Paris, France, Pediatric Hematology-Immunology Unit, Necker Hospital, Paris, France

Recently, three human primary immunodeficiencies associated with impaired TLR signalling were described. Anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID), either X-linked recessive or autosomal dominant, is caused by hypomorphic mutations in NEMO or hypermorphic mutation in IKBA, respectively, both involved in nuclear factor-{kappa}B (NF-{kappa}B) activation. These patients present with abnormal development of ectoderm-derived structures and suffer from a broad spectrum of infectious diseases. In vitro studies of the patients' cells showed an impaired, but not abolished, NF-{kappa}B activation in response to a large set of stimuli, including TLR agonists. More recently, patients with autosomal recessive amorphic mutations in IRAK4 have been reported, presenting no developmental defect and a more restricted spectrum of infectious diseases, mostly caused by pyogenic encapsulated bacteria, principally, but not exclusively Gram-positive. In vitro studies carried out with these patients' cells showed a specific impairment of the Toll—interleukin-1 receptor (TIR)—interleukin-1 receptor associated kinase (IRAK) signalling pathway. NF-{kappa}B- and mitogen activated protein kinase (MAPK) pathways are impaired in response to all TIR agonists tested. These data, therefore, suggest that TLRs play a critical role in host defence against pyogenic bacteria, but may be dispensable or redundant for immunity to most other infectious agents in humans.

Key Words: Human TLR signalling • heritable defects • NEMO • IKBA • IRAK4 • anhidrotic ectodermal dysplasia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?